During the past decade, Sint Maartenskliniek conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sint Maartenskliniek" #1 sponsor was "Sint Maartenskliniek" with 9 trials, followed by "Radboud University Medical Center" with 4 trials sponsored, "ATRO Medical B.V." with 2 trials sponsored, "Actelion" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sint Maartenskliniek" #1 collaborator was "Radboud University Medical Center" with 5 trials as a collaborator, "Sint Maartenskliniek" with 4 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 4 trials as a collaborator, "Adelante, Centre of Expertise in Rehabilitation and Audiology" with 1 trials as a collaborator and "Avania" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Sint Maartenskliniek" are "Rheumatoid Arthritis" (6 trials), "Hypotension" (2 trials), "Ischemia" (2 trials), "Amputation" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "Sint Maartenskliniek" in a lesser frequency.

Most popular intervention types in "Sint Maartenskliniek" are "Drug" (10 trials), "Device" (6 trials), "Behavioral" (5 trials), "Other" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Hemospan (MP4OX)" (2 trials), "Placebo" (2 trials), "Voluven (HES 130/0.4)" (2 trials), "Adalimumab trough concentration" (1 trials) and "BCG Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sint Maartenskliniek" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Sint Maartenskliniek". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Sint Maartenskliniek, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sint Maartenskliniek, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 11 trials that are defined as “Not Applicable".